Sign in
4/A

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001578563-20-000018

Chief Financial Officer acquired 45,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Miller Joseph M · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2018-07-12 Grant or award : show line 1 in the form +45,000 45,000 D
Loading xslF345X03/primary_doc.xml…